- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04321200
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Michelle J Johnson, PhD
- Phone Number: 215-893-2665
- Email: johnmic@pennmedicine.upenn.edu
Study Contact Backup
- Name: Laura Prosser, PhD
- Phone Number: 215-590-2495
- Email: ProsserL@email.chop.edu
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Recruiting
- Childrens Hospital Of Philadelphia
-
Contact:
- Noor Ruwaih
- Phone Number: 267-426-7032
- Email: ruwaihn@email.chop.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Study 1: 150 infants (75 with early brain injury, 75 Control). Age 1-6 months. Study 2: 50 infants (25 with early brain injury, 25 Control). Age 1 month. Study 3: 1200 infants (400 with EBI, 400 preterm without EBI/risk for future disability, 400 controls) from video data. Age 1-6 months.
Infants without EBI/risk for future disability: Infants without known brain injuries, but with a history of preterm birth less than 32 week gestation, significant medical problems, difficulty eating, or who lack head control at 4 months of age or later will be classified as moderate risk.
Description
Infants, male and female, between 0-6 months (Infants older than 6 months before initial enrollment will be excluded).
Infants with early brain injury (EBI):
- Hydrocephalus
- Hypoxic-ischemic encephalopathy (HIE)
- Periventricular leukomalacia (PVL)
- Intraventricular hemorrhage (IVH)
- Stroke
Healthy infants (controls):
o No history of early brain injury (EBI)
Infants without EBI/risk for future disability:
- Infants without known brain injuries, but with a history of preterm birth less than 32-week gestation with significant medical problems, difficulty eating, or who lack head control at 4 months of age or later will be classified as moderate risk.
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Cross-sectional-150 infants (atypical vs typical)
Arm (Study)1: To assess the concurrent validity of a multimodal instrumented gym with existing clinical tools.
Here, using 150 infants, we will focus on converting data from an instrumented gym into estimates of the standard clinical tests.
|
Infants will lie supine on a flat surface and will be placed in the PANDA gym where they either move by themselves or will interact with an instrumented toy.
We will collect video, mat, and toy data from PANDA gym under two conditions: 1) infants playing supine without a toy and 2) infants reach, grasp and kick of the new PANDA toy.
A test session will proceed as follows: The infant will be placed on his or her back at a predetermined position on the gym mat for the 2-minute no toy condition.
Next, the toy will be given to the baby and adjusted for the infant to reach or kick.
A caregiver will be seated at the head of the baby (out of a baby's sight) to provide comfort if needed.
Testing will be done in NICU or at daycare or the rehabilitation robotics lab at University of Pennsylvania.
|
Longitudinal cohort - 50 infants (atypical vs typical)
Arm (Study) 2: To discover the features related to long-term motor development.
Here we will convert data collected longitudinally from 50 infants, using both instrumented gym and video recordings, into estimates standard clinical tests change over time and track features over developmental timescales.
|
Infants will lie supine on a flat surface and will be placed in the PANDA gym where they either move by themselves or will interact with an instrumented toy.
We will collect video, mat, and toy data from PANDA gym under two conditions: 1) infants playing supine without a toy and 2) infants reach, grasp and kick of the new PANDA toy.
A test session will proceed as follows: The infant will be placed on his or her back at a predetermined position on the gym mat for the 2-minute no toy condition.
Next, the toy will be given to the baby and adjusted for the infant to reach or kick.
A caregiver will be seated at the head of the baby (out of a baby's sight) to provide comfort if needed.
Testing will be done in NICU or at daycare or the rehabilitation robotics lab at University of Pennsylvania.
|
Cross-sectional-1500 infants (atypical vs typical)
Arm (Study) 3: To develop a computer vision-based algorithm to quantify infant motor performance from a single-camera video.
Here using video data from 1200 infants, plus those gathered from Arm 1 and Arm 2, we will extract pose data from single-camera video recordings and convert these into kinematic features and relevant scores needed to classify infant movement.
|
The parent or legal guardian will be consented first via the virtual rounding mobile app. They will also be asked to fill out general surveys including, a demographic survey, and a case report form, and a user feedback survey that provides relevant information, on both the family's and infant's medical history and experience. (see the flow-chart for the app). Within the caregiver survey, we will request the pediatrician (or primary care physician) name. We believe that with the baby name, caregiver name, zip code, and physician name, we will be able to locate the physician if needed. Parents or legal guardians or the research will be asked to collect video via the MOBILE app. They will be instructed to ensure that the infant lies supine in no more than one-layer of tight-fitting clothing (i.e. infant onesie) while calm and awake. In all cases, we will have video recordings of the baby. They will be asked to upload the video to the app. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prechtl's General Movements Assessment (GMA) score
Time Frame: 1 months
|
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA.
The GMA is a qualitative observational scale of infant movement.
Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
|
1 months
|
Prechtl's General Movements Assessment (GMA) score
Time Frame: 2 months
|
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA.
The GMA is a qualitative observational scale of infant movement.
Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
|
2 months
|
Prechtl's General Movements Assessment (GMA) score
Time Frame: 3 months
|
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA.
The GMA is a qualitative observational scale of infant movement.
Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
|
3 months
|
Prechtl's General Movements Assessment (GMA) score
Time Frame: 4 months
|
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA.
The GMA is a qualitative observational scale of infant movement.
Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
|
4 months
|
Prechtl's General Movements Assessment (GMA) score
Time Frame: 5 months
|
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA.
The GMA is a qualitative observational scale of infant movement.
Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
|
5 months
|
The Test of Infant Motor Performance (TIMP) score
Time Frame: 1 month
|
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
|
1 month
|
The Test of Infant Motor Performance (TIMP) score
Time Frame: 2 months
|
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
|
2 months
|
The Test of Infant Motor Performance (TIMP) score
Time Frame: 3 months
|
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
|
3 months
|
The Test of Infant Motor Performance (TIMP) score
Time Frame: 4 months
|
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
|
4 months
|
Alberta Infant Motor Scale (AIMS) score
Time Frame: 3 months
|
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
|
3 months
|
Alberta Infant Motor Scale (AIMS) score
Time Frame: 4 months
|
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
|
4 months
|
Alberta Infant Motor Scale (AIMS) score
Time Frame: 5 months
|
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
|
5 months
|
Alberta Infant Motor Scale (AIMS) score
Time Frame: 6 months
|
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
|
6 months
|
Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 1 months
|
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
|
1 months
|
Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 2 months
|
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
|
2 months
|
Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 3 months
|
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
|
3 months
|
Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 4 months
|
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
|
4 months
|
Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 5 months
|
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
|
5 months
|
Ability to predict The Hammersmith Infant Neurological Examination (HINE) score
Time Frame: 6 months
|
The regression R-squared resulting from regression algorithm to predict the Test of Infant Motor Performance (TIMP)
|
6 months
|
Ability to predict The Test of Infant Motor Performance (TIMP) score
Time Frame: 6 months
|
The regression R-squared resulting from regression algorithm to predict the Test of Infant Motor Performance (TIMP)
|
6 months
|
Ability to predict the Alberta Infant Motor Scale (AIMS) score
Time Frame: 6 months
|
The regression R-squared resulting from a regression algorithm to predict the Alberta Infant Motor Scale (AIMS) score
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average Path Length
Time Frame: 1 month
|
The average path length of the center of pressure during a 2 minute session on the mat
|
1 month
|
Average Path Length
Time Frame: 6 months
|
The average path length of the center of pressure during a 2 minute session on the mat
|
6 months
|
Toy contact time
Time Frame: 1 month
|
Average voluntary contact time with the Toy - including sum of contact time with each arm and each leg
|
1 month
|
Toy contact time
Time Frame: 6 months
|
Average voluntary contact time with the Toy - including sum of contact time with each arm and each leg
|
6 months
|
Toy contact frequency
Time Frame: 1 month
|
Average # of voluntary contacts with the Toy - mean of with each arm and each leg
|
1 month
|
Toy contact frequency
Time Frame: 6 month
|
Average # of voluntary contacts with the Toy - mean of with each arm and each leg
|
6 month
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michelle J Johnson, PhD, The University of Pennsylvania
Publications and helpful links
General Publications
- Novak I, McIntyre S, Morgan C, Campbell L, Dark L, Morton N, Stumbles E, Wilson SA, Goldsmith S. A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med Child Neurol. 2013 Oct;55(10):885-910. doi: 10.1111/dmcn.12246. Epub 2013 Aug 21.
- Noble Y, Boyd R. Neonatal assessments for the preterm infant up to 4 months corrected age: a systematic review. Dev Med Child Neurol. 2012 Feb;54(2):129-39. doi: 10.1111/j.1469-8749.2010.03903.x. Epub 2011 Dec 5.
- Einspieler C, Bos AF, Libertus ME, Marschik PB. The General Movement Assessment Helps Us to Identify Preterm Infants at Risk for Cognitive Dysfunction. Front Psychol. 2016 Mar 22;7:406. doi: 10.3389/fpsyg.2016.00406. eCollection 2016.
- Rydz D, Shevell MI, Majnemer A, Oskoui M. Developmental screening. J Child Neurol. 2005 Jan;20(1):4-21. doi: 10.1177/08830738050200010201.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 833180
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurodevelopmental Disorders
-
University of Missouri-ColumbiaCompletedChildren With Neurodevelopmental DisordersUnited States
-
IRCCS Eugenio MedeaRecruitingNeurodevelopmental Disorder (Diagnosis)Italy
-
NeuroModulation Technique Research InstituteCompletedAutism | Neurodevelopmental DisorderUnited States
-
National Institute of Mental Health (NIMH)RecruitingHealthy Children | Children With Neurodevelopmental Disorders | Children With Neuropsychiatric Disorders | Children With Behavioral SyndromesUnited States
-
University of StrathclydeGöteborg University; University of Aberdeen; University of Glasgow; HarimataUnknownAutism Spectrum Disorder | Other Neurodevelopmental DisorderSweden, United Kingdom
-
Iama Therapeutics S.r.l.Recruiting
-
University of AlbertaAlberta Health servicesRecruitingNeurodevelopmental DisordersCanada
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingNeurodevelopmental Disorders
-
University of North Carolina, Chapel HillNational Center for Advancing Translational Sciences (NCATS); RTI InternationalCompletedNeurodevelopmental DisordersUnited States
-
ProbiSearch SLNot yet recruitingNeurodevelopmental Disorders
Clinical Trials on PANDA Gym
-
PulseSync Pte LtdSingapore Institute of TechnologyCompletedFrailty | Sarcopenia | Muscle LossSingapore
-
University of British ColumbiaBritish Columbia Children's Hospital; Providence Health & ServicesCompletedPostoperative PainCanada
-
University of British ColumbiaCompletedPostoperative Pain | Anesthesia, ConductionCanada
-
University of British ColumbiaCompletedAcute Post-operative PainCanada
-
University College DublinUnknownArthritis, RheumatoidIreland
-
Egas Moniz - Cooperativa de Ensino Superior, CRLGinásio Clube Português; Faculdade de Motricidade Humana - Universidade de... and other collaboratorsCompletedVascular Stiffness | Cardiorespiratory FitnessPortugal
-
Sheba Medical CenterCompleted
-
Aliaa Altohamy GodaCompleted
-
Riphah International UniversityCompletedCardiac DiseasePakistan